In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi

Diagnostic Microbiology and Infectious Disease

Volumn 30, Issue 4, 1998, Pages 251-255

  Pfaller, M A ^a   Marco, F ^a   Messer, S A ^a   Jones, R N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN B DERIVATIVE; FLUCYTOSINE; ITRACONAZOLE; UNCLASSIFIED DRUG;

ACREMONIUM; ANTIFUNGAL ACTIVITY; ARTICLE; ASCOMYCETES; ASPERGILLUS; FUSARIUM; HYPHOMYCETES; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RHIZOPUS; TRICHODERMA;

ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTIFUNGAL; ASPERGILLUS; FUNGI; FUSARIUM; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PEPTIDES, CYCLIC; RHIZOPUS;

EID: 0031943562     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00246-0     Document Type: Article

References (19)

1. Abruzzo GK, Flattery AM, Gill CJ, Kong L, Smith JG, Krupa D, Pikounis VB, Kropp H, Bartizal K. Evaluation of water-soluble pneumocandin analogs L-733560, L-705589 and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother. 39:1995;1077-1081.
2. Abruzzo GK, Flattery AM, Gill CJ, Kong L, Smith JG, Pikounis VB, Balkovec JM, Bouffard AF, Dropinski JF, Rosen H, Kropp H, Bartizal K. Evaluation of the echinocandin antifungal MK-0991 (L-743,872) efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis . Antimicrob Agents Chemother. 41:1997;2333-2338.
3. Bartizal K, Gill CJ, Abruzzo GK, Flattery AM, Kong L, Scott PM, Smith JG, Leighton CE, Bouffard A, Dropinski JF, Balkovec J. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob Agents Chemother. 41:1997;2326-2332.
4. Bartizal K, Scott T, Abruzzo GK, Gill CJ, Pacholok C, Lynch L, Kropp H. In vitro evaluation of the pneumocandin antifungal agent L-733,560, a new water-soluble hybrid of L-705589 and L-731,373. Antimicrob Agents Chemother. 39:1995;1070-1076.
5. Chin NX, Weitzman I, Della-Latta P. A study of in vitro activity of L-743,792 against Fusarium, Rhizopus and Trichosporon species. Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans, LA), Abstract F34. 1996;105 American Society for Microbiology, Washington, DC.
6. Current WL, Boylan CJ, Raab PP. Anti-Pneumocystis activity of LY303366 and other echinocandin B analogs. Program and Abstracts of the 33th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans, LA), Abstract 368. 1993;186 American Society for Microbiology, Washington, DC.
7. Debono M, Gordee RS. Antibiotics that inhibit fungal cell wall development. Annu Rev Microbiol. 48:1994;471-497.
8. Espinel-Ingroff A. In vitro studies with L-743,792, a water soluble pneumocandin a comparative study . Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans, LA), Abstract F31. 1996;105 American Society for Microbiology, Washington, DC.
9. Espinel-Ingroff A, Bartlett M, Bowden R, et al. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol. 35:1997;139-143.
10. Fothergill AW, Sutton DA, Rinaldi MG. Antifungal susceptibility testing of Merck L-743,792 against a broad range of fungi. Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans, LA) Abstract F29. 1996;105 American Society for Microbiology, Washington, DC.
11. Graybill JR, Najvar LK, Luther MF, Fothergill AW. Treatment of murine disseminated candidiasis with L-743,792. Antimicrob Agents Chemother. 41:1997;1775-1777.
12. Najvar L, Graybill J, Montalbo E, Barchiesi F, Luther M. Evaluation of L-743,792 in the treatment of murine histoplasmosis. Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans, LA), Abstract F43). 1996;107 American Society for Microbiology, Washington, DC.
13. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast. Approved Standard M27-A. 1997;NCCLS, Wayne, PA.
14. Pfaller MA, Messer SA, Coffman S. In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents. Antimicrob Agents Chemother. 41:1997;763-766.
15. del Poeta M, Schell WA, Perfect JR. In vitro antifungal activity of L-743,792 against a variety of clinically important moulds. Antimicrob Agents Chemother. 41:1997;1835-1836.
16. Powles MA, Anderson J, Liberator P, Schmatz DM. Efficacy of semisynthetic pneumocandin analog L-743,792 against Pneumocystis carinii in murine models. Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans, LA), Abstract F42. 1996;107 American Society for Microbiology, Washington, DC.
17. Vazquez JA, Lynch M, Boikov D, Sobel JD. In vitro activity of a new pneumocandin antifungal, L-743,792, against azole-susceptible and -resistant Candida species. Antimicrob Agents Chemother. 41:1997;1612-1614.
18. Zeckner D, Butler T, Boylan C, Boyll B, Lin Y, Raab P, Schmidtke J, Current W. LY303366, activity against systemic aspergillosis and histoplasmosis in murine models. Program and Abstracts of the 33th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans, LA), Abstract 364. 1993;186 American Society for Microbiology, Washington, DC.
19. Zeckner D, Butler T, Boylan C, Boyll B, Lin Y, Raab P, Schmidtke J, Current W. LY303366, activity in a murine systemic candidiasis model. Program and Abstracts of the 33th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans, LA), Abstract 365. 1993;186 American Society for Microbiology, Washington, DC.